Creepy drug company dumped opioids into Washington state black market

❝ After spending millions to combat the opioid epidemic ravaging its citizens, the working-class city of Everett, Washington, is taking the maker of opioid painkiller OxyContin to federal court. The city claims that the drug maker, Purdue Pharma, knowingly sold to black markets out of pure greed, enabling the devastating epidemic hitting Everett and the rest of the country.

❝ …Everett accuses Purdue Pharma of “knowingly, recklessly, and/or negligently supplying OxyContin to obviously suspicious physicians and pharmacies and enabling the illegal diversion of OxyContin into the black market, including to drug rings, pill mills, and other dealers for dispersal of the highly addictive pills in Everett.” Purdue’s goal, Everett alleges, was to “generate enormous profits” at the expense of the people of Everett.

❝ …In 2007, the infamous drug maker and three of its executives pled guilty in federal court and paid out $634.5 million in fines for purposefully misleading regulators, doctors, and patients about the addictiveness of their opioid painkiller. Around the same time, Purdue was also sued by several states, including Washington, over similar allegations. Purdue agreed to a $19.5 million multi-state settlement. And in 2015, Purdue settled a case with Kentucky, agreeing to pay $24 million…

In other words, criminal behavior ain’t anything new for these creeps.

4 thoughts on “Creepy drug company dumped opioids into Washington state black market

  1. J.P. says:

    A pharma company that spent $500,000 trying to keep pot illegal just got DEA approval for synthetic marijuana https://www.washingtonpost.com/news/wonk/wp/2017/03/24/a-pharma-company-that-spent-500000-trying-to-keep-pot-illegal-just-got-dea-approval-for-synthetic-marijuana/ Insys is also the subject of numerous state and federal criminal investigations, as well as a shareholder lawsuit, over its aggressive marketing of a product containing the potent and deadly opioid painkiller fentanyl. In December, the FBI arrested the company’s former chief executive and five other executives on charges that they “paid kickbacks and committed fraud to sell a highly potent and addictive opioid that can lead to abuse and life threatening respiratory depression.” In addition to its synthetic marijuana products, Insys is also developing a drug to treat opioid overdose.
    See also https://img.washingtonpost.com/wp-apps/imrs.php?src=https://img.washingtonpost.com/blogs/wonkblog/files/2016/07/pot_prescriptions4.png&w=1484

  2. Murder will out says:

    McCaskill investigating opioid producers http://thehill.com/homenews/state-watch/326086-mccaskill-investigating-opioid-producers Sen. Claire McCaskill (D-Mo.) said Tuesday her office has asked Purdue, Janssen/Johnson & Johnson, Insys, Mylan and Depomed to turn over internal studies that projected the risks of misuse, abuse or addiction to the powerful painkillers. McCaskill’s office said it will investigate whether those manufacturers have contributed to the growing opioid epidemic that has claimed nearly 200,000 lives in the last 15 years.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s